Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasiglifam in T2DM with CKD Stage 4/5
NCT02015780Phase 3Withdrawn
- Sponsor
- Takeda
- Start
- Dec 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Planned start Dec 2013; status: withdrawn.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02015780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015780.